Work

Abstract 5612: Taletrectinib, a next generation selective ROS1 inhibitor, inhibits growth of ROS1 wild-type and ROS1-G2032R xenografts

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5612

Authors: Hitisha K. Patel, Laura Heller, Kevin Bowman, Zheyi Hu, Yan Zhang, Irma M. Grossi, Max Pan, Gary Hattersley

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409632723

Cites:

Cited by: 1

Related to: 10